Abstract

Indomethacin 2% in Pluronic Lecithin Organogel

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2008 - Arthritis and Immunological Diseases

Page(s): 543

Download in electronic PDF format for $75
  • Indomethacin 2% in Pluronic Lecithin Organogel Page 1

Abstract

A formulation for preparing Indomethacin 2% in Pluronic Lecithin Organogel. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • indomethacin
  • nonsteroidal anti-inflammatory drugs
  • NSAIDs
  • pain control
  • pain relief
  • analgesia
  • analgesic
  • formulation
  • topical preparations
  • transdermal administration
  • musculoskeletal disorders
  • muscular pain
  • joint pain
  • inflammation

Related Categories

  • FORMULATIONS
  • PAIN MANAGEMENT
  • DOSAGE FORMS/DRUG CARRIERS
  • MUSCULOSKELETAL DISORDERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2008
Pg. 543
Indomethacin 2% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
Mar/Apr 2004
Pg. 101-105
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010
Pg. 200-203
Topical Medications for Orofacial Neuropathic Pain
Author(s): Bramwell Bethany L
May/Jun 2010
Pg. 204-206
Managing Pain with Transdermal Ketoprofen
Author(s): Williams KaCee D
Jul/Aug 2014
Pg. 278-286
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024
Pg. 100-109
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
May/Jun 2014
Pg. 256-261
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Author(s): Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
Nov/Dec 2008
Pg. 541
Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel
Author(s): Allen Loyd V Jr
May/Jun 2009
Pg. 182-190
Update on Managing Neuropathic Pain
Author(s): McNulty Jack P, Muller George
Jul/Aug 2015
Pg. 295-300
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Mar/Apr 2024
Pg. 111-116
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Nov/Dec 2010
Pg. 514
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
Nov/Dec 2006
Pg. 458
Indomethacin 2-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jan/Feb 2006
Pg. 14-18
View Sample
Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery
Author(s): Heim Bob
Nov/Dec 2010
Pg. 513
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
Nov/Dec 2008
Pg. 498-504
Case Reports: Compounding to Relieve Arthritis Pain
Author(s): Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
Sep/Oct 2013
Pg. 419
Indomethacin 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Nov/Dec 2008
Pg. 544
Ketorolac Tromethamine 2% Topical Gel
Author(s): Allen Loyd V Jr